C86.11
C86.11 — Hepatosplenic T-cell lymphoma, in remission
Billable / specific codeICD-10-CM
C86.11 is a billable, specific ICD-10-CM code for hepatosplenic t-cell lymphoma, in remission. It is valid for submission on a claim.
Risk adjustment
C86.11 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 20 Lung and Other Severe Cancers1.136 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C86.11 is named in 29 Medicare coverage policies — 29 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C86.1. If C86.11 is not quite right, the correct code is usually one of these.
Questions about C86.11
- Is C86.11 a billable ICD-10-CM code?
- Yes. C86.11 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C86.11 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).